<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00099697</url>
  </required_header>
  <id_info>
    <org_study_id>AG0013</org_study_id>
    <secondary_id>5P60AG013629</secondary_id>
    <secondary_id>5R01AG020076</secondary_id>
    <secondary_id>5K23RR016191</secondary_id>
    <secondary_id>3P30DK056341</secondary_id>
    <secondary_id>5P60DK020579</secondary_id>
    <secondary_id>2M01RR000036</secondary_id>
    <nct_id>NCT00099697</nct_id>
  </id_info>
  <brief_title>Biologic Effects of Dehydroepiandrosterone (DHEA) in Humans</brief_title>
  <official_title>Biologic Effects of DHEA in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute on Aging (NIA)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether DHEA replacement therapy decreases
      abdominal fat and improves insulin sensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies on rats and mice have shown that the adrenal hormone dehydroepiandrosterone (DHEA)
      reduces abdominal visceral fat and protects against insulin resistance. This study was done
      to learn if DHEA replacement therapy decreases abdominal obesity and improves insulin action
      in humans.

      Participants were randomly assigned to receive 50 mg per day of DHEA or a placebo at bedtime
      for 6 months. Participants underwent magnetic resonance imaging (MRI) and oral glucose
      tolerance tests at the beginning and conclusion of the study. Other tests included
      measurements of hormones and lipids.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2001</start_date>
  <completion_date type="Actual">February 2004</completion_date>
  <primary_completion_date type="Actual">February 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6-month change in visceral and subcutaneous abdominal fat</measure>
  </primary_outcome>
  <enrollment>56</enrollment>
  <condition>Aging</condition>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DHEA</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  65 to 78 years old

          -  Physically healthy

          -  Non-smoker

          -  On stable medications for at least 6 months

          -  Stable body weight for the past year

        Exclusion Criteria:

          -  Serious active medical problems

          -  Hormone therapy

          -  Abnormal PSA (prostate specific antigen) in men
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John O. Holloszy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dennis T. Villareal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hansen PA, Han DH, Nolte LA, Chen M, Holloszy JO. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am J Physiol. 1997 Nov;273(5 Pt 2):R1704-8.</citation>
    <PMID>9374813</PMID>
  </reference>
  <reference>
    <citation>Han DH, Hansen PA, Chen MM, Holloszy JO. DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J Gerontol A Biol Sci Med Sci. 1998 Jan;53(1):B19-24.</citation>
    <PMID>9467418</PMID>
  </reference>
  <reference>
    <citation>Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf). 2000 Nov;53(5):561-8.</citation>
    <PMID>11106916</PMID>
  </reference>
  <results_reference>
    <citation>Villareal DT, Holloszy JO. Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA. 2004 Nov 10;292(18):2243-8.</citation>
    <PMID>15536111</PMID>
  </results_reference>
  <verification_date>December 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2004</study_first_submitted>
  <study_first_submitted_qc>December 17, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2004</study_first_posted>
  <last_update_submitted>December 9, 2009</last_update_submitted>
  <last_update_submitted_qc>December 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2009</last_update_posted>
  <keyword>abdominal fat</keyword>
  <keyword>dehydroepiandrosterone</keyword>
  <keyword>Insulin sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydroepiandrosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

